Orbimed Advisors LLC Avrobio, Inc. Transaction History

Orbimed Advisors LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$10.54 - $19.3 $8.37 Million - $15.3 Million	-793,712 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$12.19 - $22.96 $1.59 Million - $3 Million	130,538 Added 19.68%	793,712 $13.9 Million
Q1 2020 May 15, 2020	BUY	$10.08 - $27.21 $287,017 - $774,777	28,474 Added 4.49%	663,174 $10.3 Million
Q4 2019 Feb 14, 2020	BUY	$13.05 - $21.88 $835,200 - $1.4 Million	64,000 Added 11.21%	634,700 $12.8 Million
Q3 2019 Nov 14, 2019	BUY	$14.12 - $23.44 $6.56 Million - $10.9 Million	464,700 Added 438.4%	570,700 $8.06 Million
Q2 2019 Aug 14, 2019	SELL	$13.21 - $27.29 $1.22 Million - $2.53 Million	-92,583 Reduced 46.62%	106,000 $1.72 Million
Q1 2019 May 15, 2019	SELL	$12.46 - $22.05 $639,409 - $1.13 Million	-51,317 Reduced 20.54%	198,583 $4.38 Million
Q4 2018 Feb 14, 2019	SELL	$15.43 - $32.7 $1,543 - $3,270	-100 Reduced 0.04%	249,900 $4.16 Million
Q2 2018 Aug 14, 2018	BUY	$28.08 - $31.2 $7.02 Million - $7.8 Million	250,000 New	250,000 $7.14 Million

559K

Ticker AVRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,773,900
Description
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Orbimed Advisors LLC with notifications on news.